The study aims to compare pancreatic ADC values with control subjects before and after insulin + metformin treatment in patients with newly diagnosed T2DM and evaluate its effectiveness in evaluating the response to treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.